Abstract
UDP-glucuronosyltransferase (UDP) catalyzes a broad spectrum of endobiotic and xenobiotics. It is the isoform of the UGT1 family, which are made from the complex gene locus by an alternative combination of one of the unique first exons with the commonly used exons. UDP is believed to be involved in cellular activity and signaling process associated with detoxification. In this study, rats were orally administered with 18β-glycyrrhetinic acid (GA) for four weeks before rats were sacrificed. The mRNA was extracted from the liver and cDNA was prepared by reverse transcription method. By PCR and Northern blot analysis, UGT1A8 mRNA level was found to be increased in the treatment group (P < 0.05). The results showed that the mRNA expression of UGT1A8 could be induced both by GA and the licorice extract. GA was identified to be the active component of the aqueous extract of licorice responsible for induction of UGT1A8 in the rat liver. The results suggest a transcriptional control of the UGT1A8 synthesis can be modulated by phytochemicals in the rat liver. The increased UDP activity could enhance detoxification of toxicants.
Keywords: UGT1A8, induction, transcription, expression, 18β-glycyrrhetinic acid.
Protein & Peptide Letters
Title:18β-glycyrrhetinic Acid Induces UDP-glucuronosyltransferase in Rats
Volume: 20 Issue: 12
Author(s): Kai Woo Lee and Wing Shing Ho
Affiliation:
Keywords: UGT1A8, induction, transcription, expression, 18β-glycyrrhetinic acid.
Abstract: UDP-glucuronosyltransferase (UDP) catalyzes a broad spectrum of endobiotic and xenobiotics. It is the isoform of the UGT1 family, which are made from the complex gene locus by an alternative combination of one of the unique first exons with the commonly used exons. UDP is believed to be involved in cellular activity and signaling process associated with detoxification. In this study, rats were orally administered with 18β-glycyrrhetinic acid (GA) for four weeks before rats were sacrificed. The mRNA was extracted from the liver and cDNA was prepared by reverse transcription method. By PCR and Northern blot analysis, UGT1A8 mRNA level was found to be increased in the treatment group (P < 0.05). The results showed that the mRNA expression of UGT1A8 could be induced both by GA and the licorice extract. GA was identified to be the active component of the aqueous extract of licorice responsible for induction of UGT1A8 in the rat liver. The results suggest a transcriptional control of the UGT1A8 synthesis can be modulated by phytochemicals in the rat liver. The increased UDP activity could enhance detoxification of toxicants.
Export Options
About this article
Cite this article as:
Lee Woo Kai and Ho Shing Wing, 18β-glycyrrhetinic Acid Induces UDP-glucuronosyltransferase in Rats, Protein & Peptide Letters 2013; 20 (12) . https://dx.doi.org/10.2174/092986652012131112124033
DOI https://dx.doi.org/10.2174/092986652012131112124033 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Genomic Organization and Control of the Grb7 Gene Family
Current Genomics Restoring p53 Function in Cancer: Novel Therapeutic Approaches for Applying the Brakes to Tumorigenesis
Recent Patents on Anti-Cancer Drug Discovery Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists
Current Topics in Medicinal Chemistry Adeno-Associated Viral Vector Mediated Expression of Broadly- Neutralizing Antibodies Against HIV-Hitting a Fast-Moving Target
Current HIV Research Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better...
Current Pharmaceutical Design The Association between Tumor-associated Macrophages and Glioblastoma: A Potential Target for Therapy
Current Pharmaceutical Design An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting
Current Pharmaceutical Design Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia
Current Pharmacogenomics Fyn Kinase in Brain Diseases and Cancer: The Search for Inhibitors
Current Medicinal Chemistry Leptin, Estrogens and Cancer
Mini-Reviews in Medicinal Chemistry Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress
Current Topics in Medicinal Chemistry Functional Role of Glycosphingolipids in Cancer
Current Medicinal Chemistry Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients
Current Drug Targets Artesunate Enhances the Antiproliferative Effect of Temozolomide on U87MG and A172 Glioblastoma Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Design, Synthesis, Molecular Docking Study and Anti-Hepatocellular Carcinoma Evaluation of New Bis-Triazolothiadiazines
Mini-Reviews in Medicinal Chemistry Comparison Between the Maximum Standard Uptake Value and the Ratio of Lymph Node to Primary Tumor Attenuation in Head and Neck Cancers: A Prospective Study
Current Medical Imaging Epigenetic Alterations of the Wnt/β -Catenin Pathway in Human Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacological Exploitation of Indole-3-Carbinol to Develop Potent Antitumor Agents
Mini-Reviews in Medicinal Chemistry Identification of a Novel Epithelial-to-mesenchymal-related Gene Signature in Predicting Survival of Patients with Hepatocellular Carcinoma
Combinatorial Chemistry & High Throughput Screening